OncXerna Therapeutics Company

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

Total Funding: 96500000
Headquarters: Waltham, Massachusetts, United States
Funding Status: Early Stage Venture
Employee Number: 11-50
Last Funding Type: Series B
Founded Date: 2018-01-01
Industry: Gene therapy